|
Antagonizing vasoactive intestinal peptide (VIP) receptors with Muc16CD-directed armored CAR T cells for pancreatic cancer. |
| |
|
Patents, Royalties, Other Intellectual Property - Patent for multi-cytokine particles for CAR T manufacturing; Patent for VIPR antagonist secreting CAR T cells |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Achieve Clinics |
Leadership - Achieve Clinics |
Stock and Other Ownership Interests - Achieve Clinics |
| |
|
Employment - Achieve Clinics |
Leadership - Achieve Clinics |
Stock and Other Ownership Interests - Achieve Clinics |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Leadership - CAMBIUM MEDICAL TECHNOLOGIES; CAMBIUM MEDICAL TECHNOLOGIES |
Stock and Other Ownership Interests - CAMBIUM MEDICAL TECHNOLOGIES; CAMBIUM MEDICAL TECHNOLOGIES; Cerus; Chimerix; Chimerix |
Honoraria - Karyopharm Therapeutics; Kite, a Gilead company; Novartis; Pharmacyclics; Verastem |
Consulting or Advisory Role - Alimera Sciences; Cambium Medical Technologies; Karyopharm Therapeutics; Kite, a Gilead company; Novartis; Partners Healthcare; Pharmacyclics; Verastem |
Research Funding - Amgen; Juno Therapeutics; Novartis; Partners Healthcare; Partners Healthcare; Verastem |
Patents, Royalties, Other Intellectual Property - Receive Royalties from patent on preparing platelet lysate that has been licensed to Cambium Medical Technologies |
Travel, Accommodations, Expenses - Pharmacyclics |
Other Relationship - Janssen Oncology; Janssen Oncology |
| |
|
Patents, Royalties, Other Intellectual Property - Patent for multi-cytokine particle for CAR T manufacturing; Patent for VIPR antagonist secreting CAR T |